Loading...
Pembrolizumab-Induced Pancytopenia: A Case Report
INTRODUCTION: Programmed death receptor-1 blockade with pembrolizumab is approved by the US Food and Drug Administration to treat patients with metastatic melanoma. Activating T cells to fight cancer may cause immune-mediated adverse events. Pembrolizumab-induced pancytopenia has not been previously...
Na minha lista:
| Udgivet i: | Perm J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Permanente Journal
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528855/ https://ncbi.nlm.nih.gov/pubmed/28746020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/17-004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|